ASKA Pharmaceutical Holdings Co Ltd
TSE:4886

Watchlist Manager
ASKA Pharmaceutical Holdings Co Ltd Logo
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Watchlist
Price: 2 050 JPY 0.69% Market Closed
Market Cap: 58.1B JPY
Have any thoughts about
ASKA Pharmaceutical Holdings Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one ASKA Pharmaceutical Holdings Co Ltd stock under the Base Case scenario is 3 410.94 JPY. Compared to the current market price of 2 050 JPY, ASKA Pharmaceutical Holdings Co Ltd is Undervalued by 40%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
3 410.94 JPY
Undervaluation 40%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
ASKA Pharmaceutical Holdings Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
ASKA Pharmaceutical Holdings Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ASKA Pharmaceutical Holdings Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about ASKA Pharmaceutical Holdings Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

2 050 JPY
+0.69%
+0.69%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

ASKA Pharmaceutical Holdings Co Ltd
JP
Pharmaceuticals
Market Cap
58.1B JPY
IPO
Apr 1, 2021
Employees
-
Japan
Market Cap
58.1B JPY
Industry
Pharmaceuticals
IPO
Apr 1, 2021
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about ASKA Pharmaceutical Holdings Co Ltd

Provide an overview of the primary business activities
of ASKA Pharmaceutical Holdings Co Ltd.

What unique competitive advantages
does ASKA Pharmaceutical Holdings Co Ltd hold over its rivals?

What risks and challenges
does ASKA Pharmaceutical Holdings Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ASKA Pharmaceutical Holdings Co Ltd.

Provide P/S
for ASKA Pharmaceutical Holdings Co Ltd.

Provide P/E
for ASKA Pharmaceutical Holdings Co Ltd.

Provide P/OCF
for ASKA Pharmaceutical Holdings Co Ltd.

Provide P/FCFE
for ASKA Pharmaceutical Holdings Co Ltd.

Provide P/B
for ASKA Pharmaceutical Holdings Co Ltd.

Provide EV/S
for ASKA Pharmaceutical Holdings Co Ltd.

Provide EV/GP
for ASKA Pharmaceutical Holdings Co Ltd.

Provide EV/EBITDA
for ASKA Pharmaceutical Holdings Co Ltd.

Provide EV/EBIT
for ASKA Pharmaceutical Holdings Co Ltd.

Provide EV/OCF
for ASKA Pharmaceutical Holdings Co Ltd.

Provide EV/FCFF
for ASKA Pharmaceutical Holdings Co Ltd.

Provide EV/IC
for ASKA Pharmaceutical Holdings Co Ltd.

Show me price targets
for ASKA Pharmaceutical Holdings Co Ltd made by professional analysts.

What are the Revenue projections
for ASKA Pharmaceutical Holdings Co Ltd?

How accurate were the past Revenue estimates
for ASKA Pharmaceutical Holdings Co Ltd?

What are the Net Income projections
for ASKA Pharmaceutical Holdings Co Ltd?

How accurate were the past Net Income estimates
for ASKA Pharmaceutical Holdings Co Ltd?

What are the EPS projections
for ASKA Pharmaceutical Holdings Co Ltd?

How accurate were the past EPS estimates
for ASKA Pharmaceutical Holdings Co Ltd?

What are the EBIT projections
for ASKA Pharmaceutical Holdings Co Ltd?

How accurate were the past EBIT estimates
for ASKA Pharmaceutical Holdings Co Ltd?

Compare the revenue forecasts
for ASKA Pharmaceutical Holdings Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of ASKA Pharmaceutical Holdings Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ASKA Pharmaceutical Holdings Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of ASKA Pharmaceutical Holdings Co Ltd compared to its peers.

Compare the P/E ratios
of ASKA Pharmaceutical Holdings Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing ASKA Pharmaceutical Holdings Co Ltd with its peers.

Analyze the financial leverage
of ASKA Pharmaceutical Holdings Co Ltd compared to its main competitors.

Show all profitability ratios
for ASKA Pharmaceutical Holdings Co Ltd.

Provide ROE
for ASKA Pharmaceutical Holdings Co Ltd.

Provide ROA
for ASKA Pharmaceutical Holdings Co Ltd.

Provide ROIC
for ASKA Pharmaceutical Holdings Co Ltd.

Provide ROCE
for ASKA Pharmaceutical Holdings Co Ltd.

Provide Gross Margin
for ASKA Pharmaceutical Holdings Co Ltd.

Provide Operating Margin
for ASKA Pharmaceutical Holdings Co Ltd.

Provide Net Margin
for ASKA Pharmaceutical Holdings Co Ltd.

Provide FCF Margin
for ASKA Pharmaceutical Holdings Co Ltd.

Show all solvency ratios
for ASKA Pharmaceutical Holdings Co Ltd.

Provide D/E Ratio
for ASKA Pharmaceutical Holdings Co Ltd.

Provide D/A Ratio
for ASKA Pharmaceutical Holdings Co Ltd.

Provide Interest Coverage Ratio
for ASKA Pharmaceutical Holdings Co Ltd.

Provide Altman Z-Score Ratio
for ASKA Pharmaceutical Holdings Co Ltd.

Provide Quick Ratio
for ASKA Pharmaceutical Holdings Co Ltd.

Provide Current Ratio
for ASKA Pharmaceutical Holdings Co Ltd.

Provide Cash Ratio
for ASKA Pharmaceutical Holdings Co Ltd.

What is the historical Revenue growth
over the last 5 years for ASKA Pharmaceutical Holdings Co Ltd?

What is the historical Net Income growth
over the last 5 years for ASKA Pharmaceutical Holdings Co Ltd?

What is the current Free Cash Flow
of ASKA Pharmaceutical Holdings Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for ASKA Pharmaceutical Holdings Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ASKA Pharmaceutical Holdings Co Ltd

Current Assets 52.4B
Cash & Short-Term Investments 13.7B
Receivables 15.6B
Other Current Assets 23.1B
Non-Current Assets 35.8B
Long-Term Investments 16.1B
PP&E 12.3B
Intangibles 3.2B
Other Non-Current Assets 4.2B
Current Liabilities 18.6B
Accounts Payable 5.8B
Accrued Liabilities 1.2B
Short-Term Debt 4B
Other Current Liabilities 7.7B
Non-Current Liabilities 5.5B
Long-Term Debt 3.7B
Other Non-Current Liabilities 1.8B
Efficiency

Earnings Waterfall
ASKA Pharmaceutical Holdings Co Ltd

Revenue
63.6B JPY
Cost of Revenue
-32.2B JPY
Gross Profit
31.4B JPY
Operating Expenses
-24.6B JPY
Operating Income
6.8B JPY
Other Expenses
-814m JPY
Net Income
6B JPY

Free Cash Flow Analysis
ASKA Pharmaceutical Holdings Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

ASKA Pharmaceutical Holdings Co Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
Negative Free Cash Flow
Positive 3-Years Revenue Growth
54/100
Profitability
Score

ASKA Pharmaceutical Holdings Co Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

ASKA Pharmaceutical Holdings Co Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Long-Term Solvency
Low D/E
High Altman Z-Score
86/100
Solvency
Score

ASKA Pharmaceutical Holdings Co Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
ASKA Pharmaceutical Holdings Co Ltd

Wall Street analysts forecast ASKA Pharmaceutical Holdings Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ASKA Pharmaceutical Holdings Co Ltd is 2 499 JPY with a low forecast of 2 424 JPY and a high forecast of 2 625 JPY.

Lowest
Price Target
2 424 JPY
18% Upside
Average
Price Target
2 499 JPY
22% Upside
Highest
Price Target
2 625 JPY
28% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ASKA Pharmaceutical Holdings Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ASKA Pharmaceutical Holdings Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one ASKA Pharmaceutical Holdings Co Ltd stock?

The intrinsic value of one ASKA Pharmaceutical Holdings Co Ltd stock under the Base Case scenario is 3 410.94 JPY.

Is ASKA Pharmaceutical Holdings Co Ltd stock undervalued or overvalued?

Compared to the current market price of 2 050 JPY, ASKA Pharmaceutical Holdings Co Ltd is Undervalued by 40%.

Back to Top